Anagrelide

CHEMBL760 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

256.1 g/mol

LogP

1.6

Phase

4

This medication reduces the production of platelets by interfering with the maturation of the cells that give rise to them in the bone marrow. It is used to lower dangerously high platelet counts in conditions such as essential thrombocythemia.

Peso molecular

256,0800 g/mol

LogP

1,60

TPSA

44,70 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Leucemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1

InChI

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

Molecular Formula

C10H7Cl2N3O

HBD / HBA

1 / 2

Enlaces Rotables

0

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This medication reduces the production of platelets by interfering with the maturation of the cells that give rise to them in the bone marrow. It is used to lower dangerously high platelet counts in conditions such as essential thrombocythemia.

Yes, Anagrelide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL760. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 135409400. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Anagrelide en PillFYI

Estructura

Datos Rápidos

Fórmula: C10H7Cl2N3O
Sinónimos: 1

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.